Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 490

Corporates drive Momenta to $1bn valuation

Tencent and existing backer Nio Capital both invested as autonomous driving software developer Momenta took its overall funding to $200m.

Oct 19, 2018

SoftBank Vision Fund seeks $9bn in debt

The fund is reportedly lining up the debt financing from the banks serving as underwriters for the $27bn IPO of SoftBank's wireless division.

Oct 18, 2018

Swiggy gets ready to swallow $900m

The food ordering platform has reportedly drawn up a term sheet for a $900m primary and secondary round led by Naspers and backed by Tencent.

Oct 18, 2018

Careem clears $200m in new funding

Al Tayyar and Rakuten are reportedly among the existing investors that provided $200m for on-demand ride platform Careem at a $2bn valuation.

Oct 18, 2018

Edianzu downloads $60m in series D round

Source Code Capital and an unnamed sovereign wealth fund have provided capital for Edianzu, the IT equipment supplier backed by Lakala.

Oct 18, 2018

Kymco kicks in $65m for Twenty Two Motors

The two-wheeled vehicle producer is acquiring a stake greater than 25% in electric scooter developer and new strategic partner Twenty Two.

Oct 18, 2018

Chehaoduo shifts into next round with $162m

Seven months after raising $818m in a series C round led by Tencent, Chehaoduo has added $162m in series C-plus funding alongside a $430m commitment from the city of Kunshan.

Oct 17, 2018

Zhizhangyi zips to series B funding

The mobile cybersecurity technology developer has added $28.8m in a Gaocheng Capital-led round that came just over a year after a Fosun RZ-led round.

Oct 17, 2018

Dentsu joins Scrum in competitive game

Dentsu and Scrum Ventures have formed an accelerator for sports technology startups known as Sports Tech Tokyo.

Oct 16, 2018

Innovent advances closer to $500m IPO

Legend Holdings, Eli Lilly, Ping An, China Life and Taikang Insurance are in line for exits as Innovent Biologics gears up for an initial public offering sized at $400m to $500m.

Oct 16, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here